Pre-dialysis chronic kidney disease progression over 4 years in the context of the Public Health System in Brazil: is ethnicity a factor?
DOI:
https://doi.org/10.34019/1982-8047.2021.v47.34181Palabras clave:
Renal Insufficiency, Chronic, Ethnic Groups, Noncommunicable Diseases, Disease ProgressionResumen
Introduction: The prevalence of chronic kidney disease (CKD) significantly increased, and populations with high social vulnerability tend to have worse CKD progression. Objective: To evaluate the impact of ethnicity on the control of pre-dialytic CKD in a Brazilian Unified Health System interdisciplinary outpatient clinic. Material and Methods: Data of 1,992 CKD patients were retrospectively collected from August/2010 to December/2014. Patients referred by primary health care, >18 years, ≥ two consultations were included. Sociodemographic data were collected upon admission; clinical and laboratory data were obtained at each consultation. Patients were divided into groups according to skin colour (self-identified). A descriptive analysis was performed; variables were compared using ANOVA, chi-square or Mann-Whitney U tests. Variables associated with the delta of the estimated glomerular filtration rate (eGFR) were evaluated using linear regression, adjusting for confounding variables. Results: 25.1% were black, 34.4% brown, and 40.5% white. Approximately 51.2% had income ≤ two minimum wages, 84.8% had low level education, 14.0% were illiterate. Black patients were younger and had lower education level; they had higher systolic blood pressure, total cholesterol, high-density lipoproteins, intact parathyroid hormone; their haemoglobin and vitamin D were lower. The median annual eGFR loss was 0 (P25 −6.70, P75 +8.76), 36.5% had rapid eGFR loss (>5 ml/min/year). Only use of angiotensin-converting enzyme inhibitors and low proteinuria were determined as significant for the outcome (RR: 0.92, CI: 0.010–0.684, p=0.02; RR: 0.8, CI: 0.998-0.999, p=0.001). Conclusion: Ethnicity did not impact CKD progression, even though black patients presented clinical and sociodemographic characteristics associated with worse disease progression.
Descargas
Citas
Fleury S, Carvalho A. INAMPS. Rio de Janeiro: Fundação Getúlio Vargas; 1998. [citado em 2020 jul 14]. Acessado em: <http://www.fgv.br/cpdoc/acervo/dicionarios/verbete-tematico/instituto-nacional-de-assistencia-medica-da-previdencia-social-inamps>.
Castro MC, Massuda A, Almeida G, Menezes-Filho NA, Andrade MV, Noronha KVMS et al. Brazil’s unified health system: the first 30 years and prospects for the future. The Lancet. 2019; 394:345-56. http://dx.doi.org/10.1016/S0140-6736(19)31243-7
Instituto Brasileiro de Geografia E Estatística (BR). Desigualdades sociais por cor ou raça no Brasil.
Instituto de Pesquisa Econômica Aplicada (BR). Atlas da violência. [citado em 2020 jul 16]. Acessado em: <https://www.ipea.gov.br/atlasviolencia/filtros-series/3/violencia-por-raca-e-genero>.
Leal MC, Gama SGN, Pereira APE, Pacheco VE, Carmo CN, Santos RV. A cor da dor: iniquidades raciais na atenção pré-natal e ao parto no Brasil. Cad Saúde Pública. 2017; 33 Sup 1:e00078816. doi: 10.1590/0102-311X00078816
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Indicadores de vigilância em saúde descritos segundo a variável raça/cor, Brasil. Brasília: Ministério da Saúde; 2017.
Ministério da Saúde (BR). Manual de doenças mais importantes, por razões étnicas, na população brasileira afro-descendente. Brasília: 2001. [citado em 2020 jul 17]. Acessado em: <http://bvsms.saude.gov.br/bvs/publicacoes/cd06_09.pdf>.
Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang G et al. Global kidney health atlas: a report by the International Society of Nephrology on the Global Burden of End-stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across world countries and regions. Brussels: International Society of Nephrology; 2019.
Piccolli AP, Nascimento MM, Riella MC. Prevalence of chronic kidney disease in a population in southern Brazil (pro-renal study). J Bras Nefrol. 2017; 39(4):384-90. 10.5935/0101-2800.20170070
Nascimento MM, Riella M. Raising awareness of chronic kidney disease in a Brazilian urban population. Braz J Med Biol Res. 2009; 42(8):750-5. http://dx.doi.org/10.1590/S0100-879X2009000800010.
Bastos RMR, Bastos MG, Ribeiro LC, Bastos RV, Teixeira MTB. Prevalence of chronic kidney disease, stages 3, 4 and 5 in adults. Rev Assoc Med Bras. 2009; 55(1):40-4. PMid:19360276.
Sociedade Brasileira de Nefrologia (BR). Censo da Sociedade Brasileira de Nefrologia 2019. [citado em 2020 jul 16]. Acessado em: <https://www.sbn.org.br/>.
Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015; 35(3):222-36. doi: 10.1016/j.semnephrol.2015.04.008
Hounkpatin HO, Fraser SDS, Honney R, Dreyer G, Brettle A, Roderick PJ. Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review. BMC Nephrology. 2020; 21:217. https://doi.org/10.1186/s12882-020-01852-3
Scliar M. História do conceito de saúde. PHYSIS: Rev Saúde Coletiva. 2007; 17(1):29-41.
Levin A, Lewis M, Mortiboy P, Faber S, Hare I, Porter EC et al. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis. 1997; 29:533-40. 10.1016/s0272-6386(97)90334-6
Pereira AC, Carminatti M, Fernandes NMS, Tirapani L dos S, Faria R de S, Gricenkov F et al. Associação entre fatores de risco clínicos e laboratoriais e progressão da doença renal crônica pré-dialítica. Jornal Brasileiro de Nefrologia. 2012; 34:68-75. https://doi.org/10.1590/S0101-28002012000100011
Tirapani LS, Pinheiro HS, Mansur HN, Oliveira D, Huaira RMNH, Huaira CC et al. Impacto da vulnerabilidade social nos desfechos de pacientes com doença renal crônica pré-dialítica em um centro interdisciplinar. J Bras Nefrol. 2015; 37(1):19-26. 10.5935/0101-2800.20150004
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al. CKD-EPI (chronic kidney disease epidemiology collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604-12.
Bastos MG, Kirsztajn GM. Doença renal crônica: importância do diagnóstico precoce, encaminhamento imediato e abordagem interdisciplinar estruturada para melhora do desfecho em pacientes ainda não submetidos à diálise. J Bras Nefrol. 2011; 33(1):74-87.
Instituto Brasileiro de Geografia E Estatística (BR). Pesquisa Nacional por Amostra de Domicílios Contínua Anual (PNAD Contínua) 2019. [citado em 2020 jul 18]. Acessado em: <https://sidra.ibge.gov.br/tabela/6408#notas-tabela>.
Instituto Brasileiro de Geografia E Estatística (BR). Pesquisa Nacional por Amostra de Domicílios (PNAD 2004 a 2014). [citado em 2020 jul 17]. Acessado em: <http://tabnet.datasus.gov.br/cgi/tabcgi.exe?pnad/cnv/pnadc.def>.
Hill JJ. Obesity: an emerging threat. J Natl Black Nurses Assoc. 2018; 29(2):36-9. PMID: 31022338
Olivo RE, Davenport CA, Diamantidis CJ, Bhavsar NA, Tyson CC, Hall R et al. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant. 2018; 33:992-1001 doi: 10.1093/ndt/gfx230
Moretto MC, Fontaine AM, Garcia CAMS, Neri AL, Guariento ME. Associação entre cor/raça, obesidade e diabetes em idosas da comunidade: dados do estudo FIBRA. Cad Saúde Pública; 2016; 32(10):e00081315
Chor D, Ribeiro ALP, Carvalho MS, Duncan BB, Lotufo PA, Nobre AA et al. Prevalence, awareness, treatment and influence of socioeconomic variables on control of high blood pressure: results of the ELSA-Brasil study. PLoS ONE. 2015; 10(6):e0127382. doi:10.1371/journal.pone.0127382
Yoon SS, Fryar CD, Carroll MD. Hypertension prevalence and control among adults: United States, 2011-2014. United States of America: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics (NCHS) Data Brief; 2015.
Song AY, Crews DC, Ephraim PL, Han D, Greer RC, Boyér LPL et al. Sociodemographic and kidney disease correlates of nutrient intakes among urban African Americans with uncontrolled hypertension. J Ren Nutr. 2019; Sep;29(5):399-406. 10.1053/j.jrn.2018.12.004. Epub 2019 Jan 29.
Pu J, Romanelli R, Zhao B, Azar KMJ, Hastings KG, Nimbal V et al. Dyslipidemia in special ethnic populations. Cardiol Clin. 2015; 33(2):325-33. doi:10.1016/j.ccl.2015.01.005.
Herrick KA, Storandt RJ, Afful J, Pfeiffer CM, Schleicher RL, Gahche JJ et al. Vitamin D status in the United States, 2011-2014. Am J Clin Nutr. 2019; 110(1): 150-7. doi:10.1093/ajcn/nqz037.
Moraes HAB, Mengue SS, Molina MCB, Cade NV. Fatores associados ao controle glicêmico em amostra de indivíduos com diabetes mellitus do estudo longitudinal de saúde do adulto, Brasil, 2008 a 2010. Epidemiol Serv Saude 2020; 29(3):e2018500. https://doi.org/10.5123/s1679-49742020000300017
Drummond ED, Simões TC, Andrade FB. Acesso da população brasileira adulta a medicamentos prescritos. Rev Bras Epidemiol. 2018; 21:1-14. https://doi.org/10.1590/1980-549720180007
International Society of Nephrology. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012; 2(1):1-138. doi:10.1038/kisup.2012.2
Crews DC, Charles RF, Evans MK, Zonderman, Powe NR. Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis. 2010; 55(6):992-1000. 10.1053/j.ajkd.2009.12.032. Epub 2010 Mar 6.
Norris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol. 2008; 19(7):1261-70. 10.1681/ASN.2008030276. Epub 2008 Jun 4.
Levey AS, de Jong PE, Coresh J, Nahas MEI, Astor BC, Kunihiro M et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney International. 2011; 80(1);17-28 10.1038/ki.2010.483.
Ministério da Saúde (BR). Secretaria de Gestão Estratégica e Participativa. Departamento de Apoio à Gestão Participativa e ao Controle Social. Política Nacional de Saúde Integral da População Negra : uma política para o SUS. 3. ed. Brasília: Ministério da Saúde; 2017.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2021 Luciana dos Santos Tirapani Dalamura, Lucas Fernandes Suassuna, João Eduardo Cascelli Schelb Scalla Pereira, Rosália Maria Nunes Henriques Huaira, Neimar da Silva Fernandes, Priscylla Aparecida Vieira Carmo, Natalia Maria da Silva Fernandes
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Cessão de Primeira Publicação à HU Revista
Os autores mantém todos os direitos autorais sobre a publicação, sem restrições, e concedem à HU Revista o direito de primeira publicação, com o trabalho licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento irrestrito do trabalho, com reconhecimento da autoria e crédito pela citação de publicação inicial nesta revista, referenciando inclusive seu DOI.